Green Thumb Industries (GTBIF) Depreciation & Amortization (CF) (2019 - 2026)
Green Thumb Industries' (GTBIF) quarterly Depreciation & Amortization (CF) came in at $32.4 million in Q1 2026, up 10.21% YoY from $29.4 million in Q1 2025, and down 42.41% on a QoQ basis from $56.3 million in Q4 2025.
Green Thumb Industries (GTBIF) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends
Green Thumb Industries (GTBIF) has 8 years of Depreciation & Amortization (CF) data on file, last reported at $32.4 million in Q1 2026.
- Quarterly Depreciation & Amortization (CF) rose 10.21% year-over-year to $32.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $148.5 million (up 29.26% YoY) and the FY2025 annual result came in at $145.4 million, up 28.48% from the prior year.
- Depreciation & Amortization (CF) eased to $32.4 million in Q1 2026, from $56.3 million in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $56.3 million in Q4 2025 to a low of $23.0 million in Q1 2022.
- A 5-year average of $28.7 million and a median of $27.8 million in 2024 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) rose 0.15% — and 2025, when it surged 94.37%.
- Tracing GTBIF's Depreciation & Amortization (CF) over 5 years: stood at $25.0 million in 2022, then advanced by 9.89% to $27.4 million in 2023, then gained by 5.58% to $29.0 million in 2024, then surged by 94.37% to $56.3 million in 2025, then slumped by 42.41% to $32.4 million in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $32.4 million (Q1 2026), $56.3 million (Q4 2025), and $30.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn | 241.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 24.20 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 672.30 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn | 171.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Green Thumb Industries | 1.66 Bn | 1.37 Bn | 137.87 Mn | 33.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 33.18 Mn |
| Jun 30, 2026 | 33.18 Mn |
| Mar 31, 2026 | 32.41 Mn |
| Mar 31, 2026 | 32.41 Mn |
| Dec 31, 2025 | 56.29 Mn |
| Dec 31, 2025 | 56.29 Mn |
| Sep 30, 2025 | 30.08 Mn |
| Sep 30, 2025 | 30.08 Mn |
| Jun 30, 2025 | 29.67 Mn |
| Jun 30, 2025 | 29.67 Mn |
| Mar 31, 2025 | 29.41 Mn |
| Mar 31, 2025 | 29.41 Mn |
| Dec 31, 2024 | 28.96 Mn |
| Dec 31, 2024 | 28.96 Mn |
| Sep 30, 2024 | 28.49 Mn |
| Sep 30, 2024 | 28.49 Mn |
| Jun 30, 2024 | 27.99 Mn |
| Jun 30, 2024 | 27.99 Mn |
| Mar 31, 2024 | 27.78 Mn |
| Mar 31, 2024 | 27.78 Mn |